Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

被引:4
|
作者
Polo Rodriguez, Rosa [1 ]
Galindo Puerto, Maria Jose [2 ]
Duenas, Carlos [3 ]
Gomez Candela, Carmen [4 ]
Estrada, Vicente [5 ]
Villar, Noemi G. P. [4 ]
Locutura, Jaime [6 ]
Marino, Ana [7 ]
Pascua, Javier
Palacios, Rosario [8 ]
Angel Von Wichmman, Miguel [9 ]
Alvarez, Julia [10 ]
Asensi, Victor [11 ]
Lopez Aldeguer, Jose [12 ]
Lozano, Fernando [13 ]
Negredo, Eugenia [14 ,15 ]
Ortega, Enrique [16 ]
Pedrol, Enric [17 ]
Gutierrez, Felix [18 ]
Sanz Sanz, Jesus [19 ]
Martinez Chamorro, Esteban [20 ]
机构
[1] Natl AIDS Plan, Madrid, Spain
[2] Hosp Clin Univ, Infect Dis Unit, Valencia, Spain
[3] Hosp Univ, Internal Med Infect Dis Unit, Burgos, Spain
[4] Hosp Univ La Paz, Madrid, Spain
[5] Hosp Clin Univ San Carlos, Infect Dis Unit, Madrid, Spain
[6] Univ Hosp, Infect Dis Unit, Burgos, Spain
[7] Hosp Arquitecto Marcide, Infect Dis Unit, Ferrol, Spain
[8] Hosp Virgen Victoria, Infect Dis Unit, Malaga, Spain
[9] Hosp Donostia, Infect Dis Unit, San Sebastian, Spain
[10] Hosp Univ Principe Asturias, Madrid, Spain
[11] Hosp Univ Cent Asturias, Infect Dis Unit, Oviedo, Spain
[12] Hosp La Fe, Infect Dis Unit, E-46009 Valencia, Spain
[13] Hosp Univ Valme, Infect Dis Unit, Seville, Spain
[14] Hosp Badalona Germans Trias & Pujol, Fundacio Lluita Sida, Lluita Fdn AIDS, Barcelona, Spain
[15] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[16] Hosp Univ Valencia, Infect Dis Unit, Valencia, Spain
[17] Hosp Figueres, Dept Internal Med, Girona, Spain
[18] Hosp Gen Univ, Infect Dis Unit, Elche, Spain
[19] Hosp Univ La Princesa, Infect Dis Unit, Madrid, Spain
[20] Hosp Univ Clin, Infect Dis Unit, Barcelona, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2015年 / 33卷 / 01期
关键词
HIV infection; Metabolic disorders; Cardiovascular risk;
D O I
10.1016/j.eimc.2014.05.018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The importance of the metabolic disorders and their impact on patients with HIV infection requires an individualized study and continuous updating. HIV patients have the same cardiovascular risk factors as the general population. The HIV infection per se increases the cardiovascular risk, and metabolic disorders caused by some antiretroviral drugs are added risk factors. For this reason, the choice of drugs with a good metabolic profile is essential. The most common metabolic disorders of HIV infected-patients (insulin resistance, diabetes, hyperlipidemia or osteopenia), as well as other factors of cardiovascular risk, such as hypertension, should also be dealt with according to guidelines similar to the general population, as well as insisting on steps to healthier lifestyles. The aim of this document is to provide a query tool for all professionals who treat HIV-patients and who may present or display any metabolic disorders listed in this document. (C) 2014 Elsevier Espana, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 50 条
  • [21] 2009 SIPREC consensus document executive summary: Cardiovascular prevention in subjects with impaired fasting glucose or impaired glucose tolerance
    Volpe M.
    Borghi C.
    Cavallo Perin P.
    Chiariello M.
    Manzato E.
    Miccoli R.
    Modena M.G.
    Riccardi G.
    Sesti G.
    Tiengo A.
    Trimarco B.
    Vanuzzo D.
    Verdecchia P.
    Zaninelli A.
    Del Prato S.
    High Blood Pressure & Cardiovascular Prevention, 2010, 17 (4) : 237 - 247
  • [22] Executive Summary of the SCAI/HFSA Clinical Expert Consensus Document on the Use of Invasive Hemodynamics for the Diagnosis and Management of Cardiovascular Disease
    Givertz, Michael M.
    Fang, James C.
    Sorajja, Paul
    Dimas, Vivian
    Forfia, Paul R.
    Kapur, Navin K.
    Kern, Morton J.
    Naidu, Srihari S.
    Borlaug, Barry A.
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (06) : 487 - 491
  • [23] Consensus document for the training of residents in cardiovascular risk
    Castilla Guerra, L.
    Suarez Fernandez, C.
    Mostaza, J. M.
    Valdivielso Felices, P.
    Torres do Rego, A.
    Gomez Cerezo, J. F.
    REVISTA CLINICA ESPANOLA, 2020, 220 (09): : 587 - 591
  • [24] ACTION GUIDE FOR THE COMMUNITY PHARMACIST IN PATIENTS WITH HYPERTENSION AND CARDIOVASCULAR RISK: CONSENSUS DOCUMENT
    Sabater-Hernandez, Daniel
    de la Sierra, Alejandro
    Bellver-Monzo, Oton
    Antonio Divison, Juan
    Gorostidi, Manuel
    Perseguer-Torregosa, Zeneida
    Segura, Julian
    Tous, Salvador
    FARMACEUTICOS COMUNITARIOS, 2011, 3 (02): : 69 - 83
  • [25] State of the science conference initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS - Executive summary
    Grinspoon, Steven K.
    Grunfeld, Carl
    Kotler, Donald P.
    Currier, Judith S.
    Lundgren, Jens D.
    Dube, Michael P.
    Lipshultz, Steven E.
    Hsue, Priscilla Y.
    Squires, Kathleen
    Schambelan, Morris
    Wilson, Peter W. F.
    Yarasheski, Kevin E.
    Hadigan, Colleen M.
    Stein, James H.
    Eckel, Robert H.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 48 (04) : 369 - 380
  • [26] Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias
    Katritsis, Demosthenes G.
    Boriani, Giuseppe
    Cosio, Francisco G.
    Jais, Pierre
    Hindricks, Gerhard
    Josephson, Mark E.
    Keegan, Roberto
    Knight, Bradley P.
    Kuck, Karl-Heinz
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    Malmborg, Helena
    Oral, Hakan
    Pappone, Carlo
    Themistoclakis, Sakis
    Wood, Kathryn A.
    Young-Hoon, Kim
    Lundqvist, Carina Blomstrom
    ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2016, 5 (03) : 210 - 224
  • [27] Canadian cardiovascular society consensus conference: Peripheral arterial disease - Executive summary
    Abramson, BL
    Huckell, V
    CANADIAN JOURNAL OF CARDIOLOGY, 2005, 21 (12) : 997 - 1006
  • [28] Prevention of cardiovascular risk in renal transplantation:: a consensus document
    Morales, JM
    Molina, MG
    Campistol, JM
    del Castillo, D
    Anaya, F
    Oppenheimer, F
    Vernet, JMG
    Grinyó, JM
    Capdevila, L
    Lampreave, I
    Valdés, F
    Marcén, R
    Escuín, F
    Andrés, A
    Arias, M
    Pallardó, L
    NEFROLOGIA, 2002, 22 : 35 - 37
  • [29] Prevalence of metabolic syndrome and cardiovascular risk in patients with schizoaffective disorders
    Benabarre, A.
    Garcia-Portilla, M. P.
    Livianos, L.
    Mesa, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S323 - S324
  • [30] Cardiovascular risk and HIV infection
    Dronda, F
    MEDICINA CLINICA, 2004, 122 (08): : 301 - 303